TheStreet's Jim Cramer is asked for advice on Mannkind, which has doubled in value after an FDA panel recommended approval of its insulin drug Afreeza, but has dropped off after the FDA delayed its decision. Cramer says Visa is getting "clubbed" and he needs to look into the credit card companies a little more, but FireEye is a "high-flyer." Finally, Cramer says he is unsure if Linn Energy's recently-declared dividend is safe. Send your Twitter questions to #CramerQ on Monday mornings.

More from Video

Here Is Your Market Playbook During This Tariff-Driven Selloff

Here Is Your Market Playbook During This Tariff-Driven Selloff

Marriott CEO on Tax Cuts, Trade War Worries and China's Economy

Marriott CEO on Tax Cuts, Trade War Worries and China's Economy

These 12 Stocks Are Looking Gloomy as Trump Fuels Trade War Fears

These 12 Stocks Are Looking Gloomy as Trump Fuels Trade War Fears

What Angela Merkel's Uncertain Political Future Means for Greece's Debt Woes

What Angela Merkel's Uncertain Political Future Means for Greece's Debt Woes

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China